Varshneya Kunal, Bhattacharjya Anika, Sharma Jigyasa, Stienen Martin N, Medress Zachary A, Ratliff John K, Veeravagu Anand
Neurosurgery AI Lab & Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA.
Department of Neurosurgery, University Hospital Zurich.
Clin Spine Surg. 2022 Feb 1;35(1):E31-E35. doi: 10.1097/BSD.0000000000001229.
This was a retrospective study.
The objective of this study was to identify the impact of diabetes on postoperative outcomes in Medicare patients undergoing adult spinal deformity (ASD) surgery.
We queried the MarketScan Medicare database to identify patients who underwent ASD surgery from 2007 to 2016. Patients were then stratified based on diabetes status at the time of the index operation. Patients not enrolled in the Medicare dataset and those with any prior history of trauma or tumor were excluded from this study.
A total of 2564 patients met the inclusion criteria of this study, of which n=746 (29.1.%) were diabetic. Patients with diabetes had a higher rate of postoperative infection than nondiabetic patients (3.1% vs. 1.7%, P<0.05) within 90 days. Renal complications were also more elevated in the diabetic cohort (3.2% vs. 1.3%, P<0.05). Readmission rates were significantly higher in the diabetes cohort through of 60 days (15.2% vs. 11.8%, P<0.05) and 90 days (17.0% vs. 13.4%, P<0.05). When looking specifically at the outpatient payments, patients with diabetes did have a higher financial burden at 60 days ($8147 vs. $6956, P<0.05) and 90 days ($10,126 vs. $8376, P<0.05).
In this study, diabetic patients who underwent ASD surgery had elevated rates of postoperative infection, outpatient costs, and rates of readmissions within 90 days. Further research should investigate the role of poor glycemic control on spine surgery outcomes.
这是一项回顾性研究。
本研究的目的是确定糖尿病对接受成人脊柱畸形(ASD)手术的医疗保险患者术后结局的影响。
我们查询了MarketScan医疗保险数据库,以确定2007年至2016年期间接受ASD手术的患者。然后根据初次手术时的糖尿病状态对患者进行分层。未纳入医疗保险数据集的患者以及有任何创伤或肿瘤病史的患者被排除在本研究之外。
共有2564例患者符合本研究的纳入标准,其中n = 746例(29.1%)为糖尿病患者。糖尿病患者术后90天内的感染率高于非糖尿病患者(3.1%对1.7%,P<0.05)。糖尿病队列中的肾脏并发症也更高(3.2%对1.3%,P<0.05)。糖尿病队列在60天(15.2%对11.8%,P<0.05)和90天(17.0%对13.4%,P<0.05)的再入院率明显更高。具体看门诊费用时,糖尿病患者在60天(8147美元对6956美元,P<0.05)和90天(10126美元对8376美元,P<0.05)时的经济负担确实更高。
在本研究中,接受ASD手术的糖尿病患者术后感染率、门诊费用和90天内的再入院率均有所升高。进一步的研究应调查血糖控制不佳对脊柱手术结局的作用。